— Know what they know.
Not Investment Advice

ASRT NASDAQ

Assertio Holdings, Inc.
1W: +0.3% 1M: +0.8% 3M: +99.7% YTD: +157.1% 1Y: +3709.4% 3Y: +290.4% 5Y: +1163.4%
$23.50
Last traded 2026-06-15 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $151.9M mcap · 6M float · 5.23% daily turnover · Short 57% of daily vol

Cash Flow Trends

Operating Cash Flow
-$28M -206.7% ▼
Capital Expenditures
$0 +0.0% ▲
Free Cash Flow
-$28M -206.7% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +100.0% ▲
Net Change in Cash
-$40M -76.6% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$1M$110M-$332M-$22M-$30M
Depreciation & Amort.$29M$33M$28M$26M$30M
Stock-Based Comp.$4M$8M$9M$5M$3M
Change in Working Capital-$31M-$13M$140K$5M-$45M
Other Non-Cash Items$5M$21M$268M$12M$14M
Operating Cash Flow$6M$79M$50M$26M-$28M
— Investing Activities —
Capital Expenditures-$53K-$274K-$628K$0$0
Acquisitions (Net)-$18M-$42M$2M$0$0
Investment Purchases$0$0$0-$99M-$119M
Investment Sales$0$0$2M$50M$115M
Other Investing$0$0$0$0-$8M
Investing Cash Flow-$19M-$43M$3M-$49M-$12M
— Financing Activities —
Net Debt Issuance-$10M-$750K-$10M$0$0
Stock Repurchased-$418K-$838K-$8M-$350K$0
Dividends Paid$0$0$0$0$0
Other Financing-$6M-$13M-$26M$0-$189K
Financing Cash Flow$29M-$8M-$44M-$350K-$189K
Net Change in Cash$16M$28M$8M-$23M-$40M
Cash End of Period$37M$65M$73M$51M$10M
Free Cash Flow$5M$78M$49M$26M-$28M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms